World

More Than One in 50 People in England Carry Cancer-Causing HPV Virus - Study

According to the group of scientists that compiled the research, there is reason to believe that particular activities may increase the likelihood of transmitting the HPV virus, such as smoking and engaging in oral sex.
Sputnik

A new study published in the British Medical Journal Open has found that more than one in 50 people in England are carrying the carcinogenic causing agent, ‘human papilloma virus’ (HPV) in their throats.

The study, which is the largest ever to have analyzed the spread of the infection, reveals that approximately 2.2 percent of those tested as part of the research was discovered to have the virus dormant in their system.

The latest study sampled 700 men and woman who were tested for the HPV virus. At the same time, the subjects were asked probing questions about their lifestyle choices, including about their sexual history, in an effort to draw a connection between such habits and the likelihood of contracting the infection.

Twitter Afire: Bill Gates Says Trump Doesn't Know Difference Between HIV and HPV
HPV is the blanket name given to a group of viruses that affect the skin and moist membranes lining the human body. According to research, symptoms can include but are not limited to skin warts and abnormal tissue growth, which can, in some cases, increase the likelihood of forming particular types of cancer, especially of the throat and cervix.

Studies carried out in other parts of the world, such as the United States, concluded that the percentage of people infected could be as a high as one in 25 people.

The study’s publication comes on the heels of an announcement by the UK government in July that a new vaccine programme will be introduced to counter HPV for schoolboys aged 12 to 13, while girls already receive the vaccine.

One of the study’s lead researchers, Dr Vanessa Hearnden of the University of Sheffield in the UK, has been quoted as saying that: “We fully support the newly announced vaccination programme for boys, which will reduce the risk of HPV-related cancers, including throat cancer in men, and will provide further prevention of cervical cancers. However, we found the majority of individuals testing positive for high-risk strains of HPV were actually positive for strains other than those covered by the current vaccine. This shows the need to consider newer vaccines which protect against more HPV strains in the future, and for individuals to be aware of lifestyle risk factors such as the number of sexual partners and tobacco use.”

Discuss